The decision follows consultations with the FDA, which has requested new clinical trials for Covid-19 booster doses. Moderna shares fell 1.4% amid declining revenue from Covid-19 vaccines and concerns about the nomination of Robert F. Kennedy Jr. to be secretary of the Health Department. The FDA is expected to decide on the next-generation Covid-19 vaccine, part of the combination vaccine, with no anticipated delays.
Sources
Latest News
13:40
Christine Lagarde announces that the European Central Bank will make swap lines more accessible to protect the euro area from financial shocks
13:37
Youth Strike, the young people organizing simultaneous protests in several European countries for affordable housing, better wages, and reduced military spending
13:24
Government approves 130 hires for the Momaia Tunnel and winter operations
13:21
Romania will play Estonia in the Nations League playoff / The Nations League quarterfinals were also determined during the draw
13:14
Myanmar rejects the ICJ ruling recognizing the genocide committed against the Rohingya minority
See more news